The latest ad from Smallcap Discoveries has an attention-getting headline: What if you could live to 200? It's all about how one of the big ideas in pharmaceutical development has been immunotherapy, and, of course, they hint that they have a secret little stock that's leading the way. This is indeed a penny stock in every way, and it's obviously not going to enable a cure for cancer all by itself, but is it worth a look? Let's first call on the Thinkolator to figure out what stock they're talking about, just click below to... |